HIGHLIGHTS
- who: Luai M. Assaedi MD from the (UNIVERSITY) have published the research: Carbamazepine-induced reversible vitiligo, in the Journal: (JOURNAL)
- what: The authors report an additional case of carbamazepine-associated vitiligo. The authors report the case of a 60-year-old woman who developed depigmented lesions following the administration of carbamazepine for the treatment of trigeminal neuralgia.
- future: Since most of the suggested pathogeneses of drug-induced vitiligo remain speculative further studies are required to clarify its precise mechanism.
SUMMARY
Vitiligo, a dermatological disease that is psychologically debilitating, affects . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.